K-RAS antibody (GTPase Kras)

Details for Product anti-GTPase Kras Antibody No. ABIN967445, Supplier: Log in to see
Antigen
  • Kras2
  • c-Ki-ras
  • p21
  • C-K-RAS
  • CFC2
  • K-RAS2A
  • K-RAS2B
  • K-RAS4A
  • K-RAS4B
  • KI-RAS
  • KRAS1
  • KRAS2
  • NS
  • NS3
  • RASK2
  • SIIR
  • pp21
  • 0610011M09Rik
  • BC011290
  • P21
  • AI929937
  • K-ras
  • Ki-ras
  • Kras-2
  • p21B
  • ras
  • wu:fa04e08
  • wu:fc14b12
  • wu:fc23g10
  • wu:fj89d12
  • zgc:85725
  • v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog
  • GTPase KRas
  • Kirsten rat sarcoma viral oncogene
  • Kirsten rat sarcoma viral oncogene homolog
  • transcription elongation factor A (SII)-like 1
  • KRAS
  • NCU03616
  • PGTG_03066
  • Tsp_02666
  • Tsp_01642
  • rask
  • Kras
  • TCEAL1
  • Tceal1
  • kras
Reactivity
Human
231
76
55
10
8
8
5
4
4
4
4
4
4
3
2
2
2
1
1
1
Host
Mouse
169
71
Clonality (Clone)
Monoclonal ()
Conjugate
This K-RAS antibody is un-conjugated
12
12
11
7
7
7
2
2
2
2
2
2
2
2
2
2
2
Application
Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP), Western Blotting (WB)
163
98
77
42
30
30
29
26
13
11
8
4
3
2
1
1
1
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Available images

Brand BD Pharmingen™
Immunogen Human p21
Clone 6B6
Isotype IgG1
Characteristics 1. Since applications vary, each investigator should titrate the reagent to obtain optimal results.
2. Please refer to us for technical protocols.
3. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
Purification The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.
Alternative Name p21
Background P21 belongs to a class of tumor suppressors including p16 and p27 which control progression through the cell cycle by inhibiting the activity of cyclin-cdk complexes. p21 is also known as senescent cell-derived inhibitor 1 (Sdi1), wild-type p53-activated fragment 1 (Waf1), Cdk-interacting protein 1 (Cip1), p21 and p53-regulated inhibitor of Cdks (Pic1). p21 mRNA is expressed at higher levels in senescent fibroblasts than in actively growing cells. When introduced into proliferating foreskin fibroblasts, p21 inhibits DNA synthesis and cell cycle arrest. p53 can activate p21 gene expression via a p53 binding site identified in the promoter of the p21 gene.
Molecular Weight 21 kDa
Research Area Cell Cycle
Application Notes Applications include immunoprecipitation (1-2 µg/1x10^6 cells), western blot analysis (1-2 µg/ml) and immunohistochemistry of paraformaldehyde-fixed cultured cells (0.5-2.5 µg/ml) and acetone-fixed, frozen and formalin-fixed paraffin-embedded (10 µg/ml) tissue sections. MCF7 human breast carcinoma cells (ATCC HTB-22) are suggested as a positive control. WI-38 human lung fibroblasts (ATCC CCL-75) treated with doxorubin (Adriamycin) can also be used as a positive control.
Restrictions For Research Use only
Format Liquid
Concentration 0.5 mg/mL
Buffer Aqueous buffered solution containing ≤0.09 % sodium azide.
Preservative Sodium azide
Precaution of Use This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C
Storage Comment Store undiluted at 4°C.
Supplier Images
Western Blotting (WB) image for anti-K-RAS antibody (GTPase Kras) (ABIN967445) Western blot analysis of p21. Lysate from MCF7 breast carcinoma cells was probed with...
 image for anti-K-RAS antibody (GTPase Kras) (ABIN967445) anti-GTPase Kras antibody (Image 2)
Western Blotting (WB) image for anti-K-RAS antibody (GTPase Kras) (ABIN967445) anti-GTPase Kras antibody (Image 3)
Product cited in: Clarke, Lotz, Chao, Mercurio: "Activation of the p21 pathway of growth arrest and apoptosis by the beta 4 integrin cytoplasmic domain." in: The Journal of biological chemistry, Vol. 270, Issue 39, pp. 22673-6, 1995 (PubMed).

Halevy, Novitch, Spicer, Skapek, Rhee, Hannon, Beach, Lassar: "Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD." in: Science (New York, N.Y.), Vol. 267, Issue 5200, pp. 1018-21, 1995 (PubMed).

el-Deiry, Harper, OConnor, Velculescu, Canman, Jackman, Pietenpol, Burrell, Hill, Wang: "WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis." in: Cancer research, Vol. 54, Issue 5, pp. 1169-74, 1994 (PubMed).

Hunter: "Braking the cycle." in: Cell, Vol. 75, Issue 5, pp. 839-41, 1994 (PubMed).

Noda, Ning, Venable, Pereira-Smith, Smith: "Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen." in: Experimental cell research, Vol. 211, Issue 1, pp. 90-8, 1994 (PubMed).

Xiong, Hannon, Zhang, Casso, Kobayashi, Beach: "p21 is a universal inhibitor of cyclin kinases." in: Nature, Vol. 366, Issue 6456, pp. 701-4, 1994 (PubMed).

el-Deiry, Tokino, Velculescu, Levy, Parsons, Trent, Lin, Mercer, Kinzler, Vogelstein: "WAF1, a potential mediator of p53 tumor suppression." in: Cell, Vol. 75, Issue 4, pp. 817-25, 1993 (PubMed).

Background publications Zhang, Grasso, McClain, Gambel, Cha, Travali, Deisseroth, Mercer: "p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation." in: Cancer research, Vol. 55, Issue 3, pp. 668-74, 1995 (PubMed).